Scarica l'app Stockscreener
8.64
4.66%
0.385
Precedente Chiudi:
$8.255
Aprire:
$8.18
Volume 24 ore:
239.95K
Relative Volume:
2.37
Capitalizzazione di mercato:
$123.91M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-1.7041
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
-24.87%
1M Prestazione:
-17.95%
6M Prestazione:
-49.36%
1 anno Prestazione:
-67.14%
Intervallo 1D:
$8.0017
$8.71
Intervallo di 1 settimana:
$7.8701
$11.61
Portata 52W:
$7.8701
$27.00
Anika Therapeutics Inc Stock (ANIK) Company Profile
Nome
Anika Therapeutics Inc
Settore
Telefono
(781) 457-9000
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Confronta ANIK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.64 | 119.02M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | B. Riley Securities | Buy |
| 2024-11-01 | Reiterato | Barrington Research | Outperform |
| 2023-08-14 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Ripresa | Stephens | Equal-Weight |
| 2022-03-09 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Iniziato | Stephens | Overweight |
| 2021-07-16 | Iniziato | UBS | Neutral |
| 2020-12-16 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-01-10 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Iniziato | BWS Financial | Sell |
| 2019-09-24 | Reiterato | Barrington Research | Outperform |
| 2019-09-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Downgrade | Sidoti | Buy → Neutral |
| 2018-07-27 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Reiterato | Barrington Research | Outperform |
| 2016-05-09 | Aggiornamento | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Anika Therapeutics Inc Borsa (ANIK) Ultime notizie
Kirby McInerney LLP Announces Investigation Against Anika Therapeutics, Inc. (ANIK) on Behalf of Investors - GlobeNewswire
Kirby McInerney LLP Announces Investigation Against Anika Therapeutics, Inc. (ANIK) on Behalf of Investors - GlobeNewswire Inc.
Published on: 2025-08-01 22:12:39 - metal.it
Anika Therapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
Anika slumps after trial setback for cartilage repair product - MSN
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2025 Earnings Call Transcript - Insider Monkey
Why is Anika Therapeutics Inc. stock attracting strong analyst attentionBeginner Investor Planner For Fast Growth - jammulinksnews.com
Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Anika Therapeutics 2025 Q2 Earnings Misses Targets as Net Loss Widens 4411.4% - AInvest
Anika Therapeutics Reports Q2 2025 Financial Results - TipRanks
Anika: Q2 Earnings Snapshot - Greenwich Time
Anika Therapeutics’ Earnings Call: A Mixed Outlook - TipRanks
Anika outlines 10%–20% commercial channel growth for 2026–2027 amid Hyalofast FDA timeline adjustment - MSN
Anika stock down on trial setback for cartilage repair product - Seeking Alpha
Anika Reports Topline Results from U.S. Pivotal FastTRACK - GlobeNewswire
Earnings call transcript: Anika Therapeutics Q2 2025 sees stock tumble despite revenue beat - Investing.com Australia
Anika Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Anika Therapeutics Q2 2025 slides: Revenue declines as OEM weakness persists - Investing.com
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Anika Therapeutics shares fall 8.87% premarket after Q2 revenue decline and Hyalofast trial miss. - AInvest
Anika Therapeutics Announces Phase III Study Results - TipRanks
Anika’s knee cartilage repair treatment misses primary endpoints By Investing.com - Investing.com Nigeria
Anika’s knee cartilage repair treatment misses primary endpoints - Investing.com
Anika Therapeutics Reports Second Quarter 2025 Financial Results - TradingView
Anika Reports Second Quarter 2025 Financial Results - GlobeNewswire
Anika Reports Mixed Q2 Results: Regenerative Solutions Soars 41% While Hyalofast Trial Misses Primary Endpoints - Stock Titan
Anika Reports Mixed Phase 3 Results: Hyalofast Shows Promise Despite Missing Primary Endpoints - Stock Titan
Combining machine learning predictions for Anika Therapeutics Inc.Pre-Market Stock Movement Summary and Review - Newser
Can Anika Therapeutics Inc. hit a new high this monthFree Risk Managed Intraday Trade Alerts - Newser
Why Anika Therapeutics Inc. stock attracts strong analyst attentionRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Anika Therapeutics Inc. Uptrend in Early Stages Indicators Say YesCapital Preserving Trade Plan Templates Shared - metal.it
Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Anika Therapeutics Inc.’s volatility index tracking explainedFree Reversal Alert Based on RSI Indicator - Newser
Advanced analytics toolkit walkthrough for Anika Therapeutics Inc.Free Reversal Alert Based on RSI Indicator - Newser
What’s the recovery path for long term holders of Anika Therapeutics Inc.Day Trading Plan with Entry Risk Management - Newser
Why Anika Therapeutics Inc. stock is on top investor watchlistsWeekly Growth Portfolio Performance Summary - Newser
Published on: 2025-07-29 10:40:40 - metal.it
Custom strategy builders for tracking Anika Therapeutics Inc.Free Short Term Buy List With Stop Protection - Newser
Technical analysis overview for Anika Therapeutics Inc. stockFree High Accuracy Alerts for ROI Traders - Newser
How did ANIK's Q4 earnings surprise impact investor sentiment? - AInvest
RSI Divergence May Trigger a Bounce in Anika Therapeutics Inc.Short Term Trading Opportunity Watch Sees Shift - metal.it
What are the latest earnings results for Anika Therapeutics Inc.AI Powered Planner Backed By Experts - jammulinksnews.com
Should I hold or sell Anika Therapeutics Inc. stock in 2025Earnings Report Alerts For Every Investor - jammulinksnews.com
Technical analysis overview for Anika Therapeutics Inc. stock Breakout Watcher with Entry and Exit Alerts - Newser
Combining machine learning predictions for Anika Therapeutics Inc. Smart Forecast Signals from AI Models - Newser
What makes Anika Therapeutics Inc. stock price move sharplyCapitalize on stocks with high profit margins - jammulinksnews.com
How does Anika Therapeutics Inc. compare to its industry peersDaily Trading Strategy To Watch Now - jammulinksnews.com
How strong is Anika Therapeutics Inc. company’s balance sheetOutstanding risk-reward balance - jammulinksnews.com
How Anika Therapeutics Inc. stock performs during market volatilityStable Growth Stock Picks - metal.it
Is Anika Therapeutics Inc. a growth stock or a value stockRapid wealth accumulation - jammulinksnews.com
Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):